Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment


                  of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 22, 2022, the Board of Directors (Board) of Medtronic plc (Company) increased the size of the Board from 10 to 11 and appointed Lidia L. Fonseca as a new director of the Company, in each case effective as of June 27, 2022. Ms. Fonseca has been appointed to serve on the Science and Technology committee and Compensation committee of the Board.

In connection with her appointment to the Board, pursuant to the Company's non-employee director compensation policy, Ms. Fonseca will be eligible to receive an annual cash retainer and a director equity grant, in each case as described under "Corporate Governance-Director Compensation" in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on October 8, 2021.

There were no arrangements or understandings between Ms. Fonseca and any other persons pursuant to which she was selected as a director, and neither Ms. Fonseca nor any of her immediate family has been a party to any transaction or currently proposed transaction with the Company that is reportable under Item 404(a) of Regulation S-K.

A press release announcing Ms. Fonseca's appointment was issued on June 27, 2022. A copy of such press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.




(d) List of Exhibits

Exhibit Number                      Description

  99.1                                Press release of Medtronic plc, dated     June 2    7, 2022
104                                 Cover Page Interactive Data File (embedded with the Inline XBRL
                                    document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses